ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,807Medicare Part D Prescriptions Filled, Including Refills

Rank: 115 out of 617

$522K Total Retail Price of All Prescriptions

Rank: 88 out of 617

418 Patients Receiving at Least One Drug in Part D
80%Patients 65 Years and Older
34% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Nebraska
Lower avg

Schedule Two
Controlled Substances

7% of this provider’s 418 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

7% of this provider’s 418 patients filled at least one prescription for a schedule three drug, compared to an average of 11%.

Risky Drugs to Seniors

3% of this provider’s 7,999 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$53 was the average price of a prescription from this provider, compared to $49 among peers.

Prescriptions per Patient

23 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Nebraska
LEVOTHYROXINE SODIUM 415 346 1 1
OMEPRAZOLE 399 327 2 3
SIMVASTATIN 367 316 3 2
METFORMIN HCL 273 219 4 9
FUROSEMIDE 244 238 5 4
WARFARIN SODIUM 233 190 6 7
ENALAPRIL MALEATE 206 186 7 34
POTASSIUM CHLORIDE 188 172 8 10
ATORVASTATIN CALCIUM 182 155 9 14
SERTRALINE HCL 182 143 9 20
METOPROLOL TARTRATE 159 135 11 11
ATENOLOL 148 125 12 17
METOPROLOL SUCCINATE 138 114 13 12
AMLODIPINE BESYLATE 135 124 14 6
ALLOPURINOL 132 115 15 27
CRESTOR 129 110 16 28
LISINOPRIL 129 120 16 5
CITALOPRAM HBR 124 87 18 18
TRAMADOL HCL 123 93 19 15
NEXIUM 120 72 20 43
PRAVASTATIN SODIUM 119 110 21 21
AMITRIPTYLINE HCL 108 84 R 22 56
HYDROCHLOROTHIAZIDE 106 86 23 13
LANTUS 102 88 24 39
ZOLPIDEM TARTRATE 100 73 25 23
MELOXICAM 100 91 25 24
LOSARTAN-HYDROCHLOROTHIAZIDE 94 94 27 46
DONEPEZIL HCL 86 85 28 30
BISOPROLOL-HYDROCHLOROTHIAZIDE 80 77 29 87
FENTANYL 79 74 S2 30 45
GEMFIBROZIL 77 36 31 105
CELEBREX 75 54 32 63
CYCLOBENZAPRINE HCL 74 43 R 33 74
LOSARTAN POTASSIUM 70 47 34 22
ENALAPRIL-HYDROCHLOROTHIAZIDE 69 69 35 183
AZITHROMYCIN 66 57 36 70
VESICARE 62 49 37 95
ALENDRONATE SODIUM 61 58 38 25
CLOPIDOGREL 60 53 39 53
CLONIDINE HCL 58 50 40 55
PREMARIN 58 41 R 40 108
HYDROCODONE-ACETAMINOPHEN 56 34 S3 42 8
ISOSORBIDE MONONITRATE ER 54 54 43 52
CEPHALEXIN 54 43 43 68
SPIRONOLACTONE 53 34 45 42
FLUTICASONE PROPIONATE 51 32 46 36
CARBIDOPA-LEVODOPA 50 26 47 69
GABAPENTIN 50 45 47 16
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on March 26, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.